The mechanism we evidenced as a podocyte depletor in FSGS is the one triggered by uPAR, which seems to be a predictor and a possibly diagnostic marker of the disease, along with podocin. This evidence concerns the gene NPHS2 and focal segmental glomerulosclerosis.